Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

36
Number of overlapping holdings
9.1%
% of FHLC's 405 holdings also in XPH
97.3%
% of XPH's 40 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FHLC |
Weight in XPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 8.2% | 5.6% | 5.6% | |
MERCK & CO. INC. | 4.8% | 4.2% | 4.2% | |
JOHNSON & JOHNSON | 6.9% | 4.0% | 4.0% | |
PFIZER INC | 3.4% | 3.8% | 3.4% | |
BRISTOL-MYERS SQUIBB CO | 2.2% | 3.9% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to XPH
UNITEDHEALTH GROUP INC | 8.0% | |
ABBVIE INC | 4.8% | |
THERMO FISHER SCIENTIFIC INC | 3.5% | |
DANAHER CORP | 3.2% | |
ABBOTT LABORATORIES | 3.1% | |
JOHNSON & JOHNSON | 2.9% | |
ELI LILLY & CO | 2.7% | |
AMGEN INC | 2.5% | |
MEDTRONIC PLC | 1.9% | |
ANTHEM INC | 1.9% |
FHLC Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A | -7.8% | |
ELANCO ANIMAL HEALTH, INC. | -5.6% | |
CATALENT INC | -5.3% | |
AXSOME THERAPEUTICS, INC. | -4.4% | |
JAZZ PHARMACEUTICALS PLC | -4.3% | |
VIATRIS, INC. | -4.3% | |
ORGANON & CO. | -3.8% | |
PERRIGO CO | -3.6% | |
INTRA-CELLULAR THERAPIES INC | -3.5% | |
ROYALTY PHARMA PLC CLASS A | -3.5% |